---
title: "Climb Bio names Breanna O’Reilly to board after Andrew Levin resigns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291458043.md"
description: "Climb Bio reshaped its board on June 29, 2026, following Andrew Levin's immediate resignation. Breanna O’Reilly was elected to the board effective immediately, with a term running through the 2027 annual meeting."
datetime: "2026-07-01T20:18:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291458043.md)
  - [en](https://longbridge.com/en/news/291458043.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291458043.md)
---

# Climb Bio names Breanna O’Reilly to board after Andrew Levin resigns

-   Climb Bio reshaped its board on June 29, 2026, following the resignation of director Andrew Levin, effective immediately. \* Breanna O’Reilly was elected to the board, effective immediately, with a term running through the 2027 annual meeting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-292567), on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CLYM.US](https://longbridge.com/en/quote/CLYM.US.md)

## Related News & Research

- [Climb Bio director Breanna Maurine Celebi files initial beneficial ownership statement](https://longbridge.com/en/news/291458885.md)
- [Climb Bio: Unique APRIL Inhibitor Profile Supports Buy Rating and Unchanged $20 Price Target](https://longbridge.com/en/news/293376610.md)
- [Standard BioTools amends 8-K to file mass cytometry sale agreement with Multiplex Bio](https://longbridge.com/en/news/294206092.md)
- [SCWorx files amendment to charter for 1-for-12 reverse stock split](https://longbridge.com/en/news/294370523.md)
- [Linde holds annual shareholder meeting, 85.65% of shares represented](https://longbridge.com/en/news/294379755.md)